Stay updated on Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial
Sign up to get notified when there's something new on the Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial page.

Latest updates to the Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check40 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check55 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check62 days agoChange DetectedThe website has updated the intervention details and contact information for the study, now listing Revital Kariv, MD as the contact and Michal Roll as the verified principal investigator, while also reflecting a revision update to v2.14.0.SummaryDifference2%
- Check91 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
Stay in the know with updates to Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial page.